00:01
When we are very young, our immune
system is not fully developed.
00:05
So immaturity can also be a cause
of secondary immunodeficiency.
00:10
Neonates have a relatively immature immune
system, particularly if delivered pre-term.
00:15
There is susceptibility to infection and this
correlates with the degree of prematurity.
00:22
Both T-cells and B-cells in the neonate are
naïve, they haven’t encountered antigen yet.
00:29
And therefore they respond
relatively slowly to infection.
00:35
In some infants there is a transient
hypogammaglobulinemia of infancy in which IgG
levels remain low following catabolism
of placentally-transferred maternal IgG.
00:49
This is usually asymptomatic.
00:52
Maternal IgG is transported across the placenta
by the neonatal IgG-Fc receptor (FcRn).
01:03
So antibodies from the mother are
picked up by FcRn and transferred
across the placenta, and released into the fetal circulation.
01:15
The newborn therefore contains the same
antibody specificities as the mother because
the antibody is coming from the mother
rather than being produced by the fetus.
01:24
In immaturity, maternal IgA and IgG in breast
milk is particularly important for the newborn.
01:33
Ingested secretory IgA protects the newborn
against microbial colonization in the gut.
01:40
Whilst ingested IgG antibodies are transported into the
infant’s circulation by the FcRn on gut epithelium.
01:50
Here we can see the serum immunoglobulin levels
in the newborn as a percent of adult values.
01:59
Our own B-cells are beginning to
make IgM antibodies before we’re
born, but only very small levels
are produced by the time of birth.
02:10
But within the months following birth, IgM levels within a
year or so reach the level that you would find in the adult.
02:20
IgG follows a little bit later on,
remember IgM is characteristic of
the primary immune response and IgG
of the secondary immune response.
02:29
And at the time of birth, there
is very little IgG in the infant’s
circulation that is being produced
by the infant’s own B-lymphocytes.
02:38
They’re just reaching the stage of maturity
when they can begin to make antibody.
02:44
IgA levels are also vanishingly small at the
time of birth but will increase over time.
02:54
However, with respect to IgG, there is in fact quite a lot
of IgG in the fetal circulation and in the newborn circulation.
03:05
And that’s because IgG is transferred across
the placenta as we’ve just seen using the FcRn.
03:15
This maternally derived antibody will begin to
be catabolised once the newborn has been born.
03:23
And IgG has a half life of
around about three weeks.
03:29
So three weeks after birth, half of the
maternal antibody will have been catabolised.
03:35
Six weeks after birth, there’ll only
be 25% of the maternal antibody.
03:39
But the infant is now beginning to make their own IgG, so
there will be a dip in the level as the maternal IgG is
catabolised, but then the infant’s own IgG will come up and
eventually there will be a rise in the overall IgG level.
04:00
Pregnancy is a condition in which
there is a natural immunosuppression.
04:06
This occurs in order to avoid rejection
of the semi-allogeneic fetus.
04:11
Remember, half of the genes in the fetus,
will have come from the male partner.
04:19
Immunosuppression is largely focused at the
maternal-fetal interface in the placenta, to stop an
immunological rejection of this semi-allogeneic
fetus where half of the genes are from the dad.
04:33
However, there is some degree of systemic
suppression of the immune response.
04:38
And pregnant women have a degree of increased
incidence and severity of infection.
04:46
There is no evidence of risk of vaccinating
pregnant women with inactivated virus
or bacterial vaccines or with toxoids,
which are inactivated bacterial toxins.
04:57
However, live virus vaccines are contraindicated because of the
theoretical risk of transmission of live virus to the fetus.